SCHEMBL758168

SCHEMBL758168

C=CC(=O)NC(C)(C)CC[N+](C)(C)C

nearest known ligand 0.49

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.49
MEN1 O00255 1/20 0.49
ALDH1A1 P00352 3/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
TSHR P16473 2/20 0.34
MAPK1 P28482 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
ATM Q13315 1/20 0.33
APOBEC3A P31941 1/20 0.32
APOBEC3G Q9HC16 1/20 0.32
ZDHHC20 Q5W0Z9 1/20 0.31
ZDHHC2 Q9UIJ5 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL192474 0.98 KMT2A (0.48) KMT2AMEN1ALDH1A1CYP3A4CYP2C9
Bromide SCHEMBL9320690 0.98 KMT2A (0.48) KMT2AMEN1ALDH1A1CYP3A4CYP2C9
Ethylenediamine SCHEMBL11573194 0.92 MEN1 (0.43) KMT2AMEN1ALDH1A1CYP3A4CYP2C9
SCHEMBL6116912 0.87 MEN1 (0.40) KMT2AMEN1ALDH1A1CYP3A4CYP2C9
SCHEMBL7115006 0.84 MEN1 (0.46) KMT2AMEN1ALDH1A1CYP3A4CYP2C9
Bromide SCHEMBL6117348 0.83 KMT2A (0.44) KMT2AMEN1ALDH1A1CYP3A4CYP2C9
SCHEMBL1533171 0.81 ALDH1A1 (0.49) KMT2AMEN1ALDH1A1CYP3A4CYP2C9
Hydrochloric Acid SCHEMBL6117097 0.81 MEN1 (0.46) KMT2AMEN1ALDH1A1CYP3A4CYP2C9
SCHEMBL5529943 0.80 MEN1 (0.38) KMT2AMEN1ALDH1A1CYP3A4CYP2C9
Hydrochloric Acid SCHEMBL1072129 0.79 ALDH1A1 (0.47) KMT2AMEN1ALDH1A1CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3071751-B1 METHOD FOR INCREASING PAPER STRENGTH KEMIRA OYJ (FI) 2022-01-05 EP claimed
EP-3464721-B1 HIGH-EFFICIENCY STRENGTH PROGRAM USED FOR MAKING PAPER IN HIGH CHARGE DEMAND SYSTEM ECOLAB USA INC (US) 2021-03-17 EP claimed
EP-2176304-B1 HIGH SOLIDS GLYOXALATED POLYACRYLAMIDE BUCKMAN LABORATORIES INT INC (US) 2020-09-02 EP claimed
EP-3044366-B9 PAPER-MAKING AID COMPOSITION AND PROCESS FOR INCREASING ASH RETENTION OF FINISHED PAPER ECOLAB USA INC (US) 2019-05-22 EP claimed
EP-3044366-B1 PAPER-MAKING AID COMPOSITION AND PROCESS FOR INCREASING ASH RETENTION OF FINISHED PAPER ECOLAB USA INC (US) 2019-01-02 EP claimed
EP-2358941-B1 BLENDS OF GLYOXALATED POLYACRYLAMIDES AND PAPER STRENGTHENING AGENTS GEORGIA PACIFIC CHEMICALS LLC (US) 2014-10-08 EP claimed
EP-2451887-B1 EMULSION STABILIZING AGENTS FOR DRILLING AND COMPLETION FLUIDS HALLIBURTON ENERGY SERV INC (US) 2014-04-30 EP claimed
EP-0998547-B1 USE OF POLYELECTROLYTES AS SEQUESTERING AGENTS HENKEL AG & CO KGAA (DE) 2011-08-24 EP claimed
EP-1558809-B1 LOW SLOUGH TISSUE PRODUCTS AND METHOD FOR MAKING SAME KIMBERLY CLARK CO (US) 2011-05-18 EP claimed
EP-1169405-B1 QUATERNARY NITROGEN CONTAINING AMPHOTERIC WATER SOLUBLE POLYMERS AND THEIR USE IN DRILLING FLUIDS AKZO NOBEL NV (NL) 2008-02-27 EP claimed
US-20080031846-A1 Compositions with enhanced antimicrobial efficacy against acanthamoebae BORAZJANI ROYA 2008-02-07 US claimed
EP-1852133-A2 Compositions with enhanced antimicrobial efficacy against acanthamoebae BAUSCH & LOMB INCORPORATED (US) 2007-11-07 EP claimed
EP-1149146-B1 USE OF PHOSPHONOUS ACID MODIFIED POLYACRYLATES AS SEQUESTERING AGENTS HENKEL KGAA (DE) 2004-12-22 EP claimed
EP-0920487-B1 COMPOSITION AND METHOD FOR INHIBITING THE DEPOSITION OF PROTEIN ON CONTACT LENS BAUSCH & LOMB (US) 2003-04-09 EP claimed
JP-2002531468-A 2002-09-24 JP claimed
EP-1137793-A2 NOVEL NUCLEIC ACID TRANSFERRING AGENTS, COMPOSITIONS CONTAINING THEM AND USES Aventis Pharma S.A. (FR) 2001-10-04 EP claimed
US-6096138-A IMMERSION IN AQUEOUS SOLUTION OF POLYQUATERNARY AMMONIUM SALT CATIONIC POLYMER BAUSCH & LOMB INCORPORATED (US) 2000-08-01 US claimed
WO-2000032803-A2 NOVEL NUCLEIC ACID TRANSFERRING AGENTS, COMPOSITIONS CONTAINING THEM AND USES AVENTIS PHARMA S.A. (FR) 2000-06-08 WO claimed
EP-0430963-B1 HYDROLYSIS RESISTANT VINYL LACTAM AMINO ACRYLAMIDE POLYMERS ISP INVESTMENTS INC (US) 1994-01-12 EP claimed
EP-0274189-B1 RIBOFLAVIN/FLUORESCENT LIGHT-INITIATED POLYMERIZATION OF WATER-SOLUBLE MONOMERS CALGON CORPORATION (US) 1990-12-27 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080031846-A1 Compositions with enhanced antimicrobial efficacy against acanthamoebae LAGE3, PKD2, CUTA KMT2A 1820/4885MEN1 1044/4885ALDH1A1 2797/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.